Renal safety of intravenous ibandronate injections in postmenopausal osteoporosis (PMO): DIVA 1-year results

被引：0
|
作者：
Civitelli, R
Emkey, R
Bolognese, M
Recker, R
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Reading Hosp, W Reading, PA USA
[3] Bethesda Hlth Res, Bethesda, MD USA
[4] Creighton Univ, Omaha, NE 68178 USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2005年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [1] Favorable renal safety profile of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year results from DIVA
    Delmas, P
    Reid, D
    Felsenberg, D
    Leigh, C
    Ward, P
    Sedarati, F
    Christiansen, C
    BONE, 2005, 36 : S419 - S420
  • [2] Favourable renal safety and tolerability profile of intravenous ibandronate injections in women with postmenopausal osteoporosis: 1-year results from diva
    Reid, DM
    Felsenberg, D
    Christiansen, C
    Leigh, C
    Ward, P
    Sedarati, F
    Delmas, PD
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 365 - 365
  • [3] Efficacy of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year findings from DIVA.
    Bolognese, M
    Reid, DM
    Langdahl, B
    Hughes, C
    Ward, P
    Masanauskaite, D
    Olszynski, WP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S96 - S96
  • [4] Intravenous ibandronate injections are at least as effective and similarly well tolerated as daily oral ibandronate in postmenopausal osteoporosis: 1-year results from DIVA
    Adami, S
    Nuti, R
    Czerwinski, E
    Hughes, C
    Ward, P
    Bonvoisin, B
    Tanko, LB
    BONE, 2005, 36 : S137 - S138
  • [5] Safety and tolerability of intravenous ibandronate injections: DIVA 1-year analysis.
    Drezner, MK
    Ste-Marie, LG
    Nuti, R
    Benhamou, C
    Leigh, C
    Ward, P
    Masanauskaite, D
    Lewiecki, EM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S396 - S396
  • [6] Intermittent intravenous ibandronate injections are at least as effective as daily oral ibandronate: 1-Year DIVA results
    Lewiecki, M
    Zaidi, M
    Drezner, M
    Recknor, C
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 802 - 802
  • [7] Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2-Year Results from the DIVA Study
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (03): : 159 - +
  • [8] Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
    Eisman, John A.
    Civitelli, Roberto
    Adaml, Silvano
    Czerwinski, Edward
    Recknor, Chris
    Prince, Richard
    Reginster, Jean-Yves
    Zaidi, Mone
    Felsenberg, Dieter
    Hughes, Claire
    Mairon, Nicole
    Masanauskaite, Daiva
    Reid, David M.
    Delmas, Pierre D.
    Recker, Robert R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 488 - 497
  • [9] Renal tolerability profile of intermittent intravenous ibandronate injections in postmenopausal women with osteoporosis: DIVA 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S125 - S125
  • [10] Intermittent intravenous ibandronate injections are an effective treatment option in postmenopausal osteoporosis: 2-year results from diva
    Eisman, J. A.
    Garcia-Hernandez, P. A.
    Ortiz-Luna, G.
    Ste-Marie, L. G.
    Hughes, C.
    Mairon, N.
    Masanauskaite, D.
    Delmas, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S212 - S212
12345